Stockreport

BRIEF-Stemline Therapeutics Q4 Loss Per Share $0.93 [Reuters]

STEMLINE THERAPEUTICS  (STML) 
Last stemline therapeutics earnings: 3/13 04:45 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.stemline.com/investor-relations
PDF BRIEF-Stemline Therapeutics Q4 Loss Per Share $0.93 | Reuters Reuters Staff 1 Min Read March 16 (Reuters) - Stemline Therapeutics Inc: * STEMLINE THERAPEUTICS REPORTS FO [Read more]